COVID-19 assay kit HISCL

IgGSARS-COV-2serum

Targets and accurately quantifies IgG antibodies against the receptor-binding domain (RBD) in the spike protein of SARS-CoV-2 To be used on the HISCL™-5000 immunoassay analyser For human serum or plasma samples High throughput of 200 samples/h Excellent performance and result quality The HISCL SARS-CoV-2 S-IgG Assay Kit for HISCL-5000 aims to help healthcare providers in monitoring and analysing temporal immunological profiles of SARS-CoV-2 infection and SARS-CoV-2 vaccine effectiveness in different population groups and areas. The assay targets IgG antibodies against the receptor-binding domain (RBD) portion situated in the S1 domain of the SARS-CoV-2 spike protein (S-protein), which play an important role in the neutralisation activity of the virus* Technical specifications Test technology - chemiluminescence enzyme immunoassay (CLEIA) Dedicated instrument - automated immunoassay system HISCL-5000 Throughput - 200 tests/h on the HISCL-5000 Expression of results - BAU/mL quantitative (calibrated against WHO international reference standard) Cut-off value - 20 BAU/mL Measurement tubes - conical 4-mL sample cup (no barcode possible) or standard sample tube (13–16 mm diameter, 75–100 mm height) with the option of barcode labelling